Andere Sprachen Portage Biotech Inc.

Aktien

A2P6BP

VGG7185A1286

PRTG

Markt geschlossen - Nasdaq Andere Börsenplätze 20:58:38 03.05.2024			% 5 Tage	% 1. Jan.
0,268 ^USD	+3,12 %		+11,57 %	-85,27 %

15.04.	Portage Biotech kündigt Pläne zur Ausweitung der Evaluierung strategischer Alternativen an	CI
12.04.	Portage Biotech kündigt Pläne zur Ausweitung der Evaluierung strategischer Alternativen an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Portage Biotech : Director Resignations - Form 6-K	02.05.
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives-Adenosine clinical development paused	15.04.
Portage biotech announces plans to expand its evaluation of strategic alternatives	15.04.
Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives	15.04.
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives	12.04.
Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives	12.04.
Portage biotech completes monetization of intensity therapeutics shares	27.03.
Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares	26.03.
Portage Biotech : Corporate Presentation - March 2024	07.03.
Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update	28.02.
Portage Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	28.02.
Portage Biotech to Pause Drug Development in PORT-2 iNKT Program, to Cut Workforce	04.01.
Portage Biotech to Evaluate Range of Strategic Options	04.01.
Portage Biotech Reports Business and Strategic Update	04.01.
Portage Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	28.11.
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update	28.11.
Portage biotech presents updates on its inkt and adenosine programs at the society for immunotherapy of cancer's 38th annual meeting	07.11.
Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting	06.11.
Portage Biotech Inc. Presents Updates on its iNKT and Adenosine Programs at the Society for Immunotherapy of Cancer's 38th Annual Meeting	06.11.
Portage Biotech Inc. announced that it has received $5.3 million in funding	03.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Portage Biotech Inc.

Aktien

A2P6BP

VGG7185A1286

PRTG

Andere Sprachen

Filter